logo
episode-header-image
Sep 2021
29m 54s

What Causes Alzheimer's?

Science History Institute
About this episode

The human brain is mysterious and complicated. So much so, one might be tempted to argue that it only makes sense that we still don’t have a cure for Alzheimer’s disease, despite decades of research. But this isn’t the whole story. We’ve partnered with Vox’s Unexplainable science podcast to talk about how Alzheimer’s researchers have been stubbornly pursuing a single theory for decades. The Amyloid Hypothesis is the reigning champ amongst pharmaceutical companies and scientific scholars and it has pushed all other theories to the wayside. Over the years scientists have developed many drugs based on the Amyloid Hypothesis but the the clinical trials keep failing. Now some researchers are starting to wonder if the reason we still don’t have a cure is that we’ve put all of our scientific eggs in one faulty basket.  You can hear more about the Alzheimer’s disease on the previous Distillations Podcast episodes: The Alzheimer’s Copernicus Problem Parts 1 and 2.

Credits:

Distillations:

Hosts: Alexis Pedrick and Elisabeth Berry Drago Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Audio Engineer: Jonathan Pfeffer

Unexplainable:

This episode was produced by Rigo Hernandez, Alexis Pedrick, Dylan Scott, and Byrd Pinkerton. It was edited by Noam Hassenfeld and Brian Resnick, with help from Meradith Hoddinott and Mandy Nguyen, who also did the fact checking. Noam Hassenfeld wrote the music, Cristian Ayala did the mixing and sound design. 

Image courtesy of Vox Media Group.

Up next
May 29
The History of the School Lunch
Feeding kids a healthy lunch every school day is a feat of science and logistics. Molded into shape by nutrition scientists who wanted to optimize children’s health, the school lunch has endured war, economic depression, and even a global pandemic. Some might say it’s all the str ... Show More
49m 51s
Feb 2025
Science, Interrupted: Part 2
Genetic engineering breakthroughs in the late 1960s and early 1970s came with a lot of promise—and peril too. Fears about what could happen with recombinant DNA experiments put scientists in the middle of a moral dilemma. Did they have a responsibility to consider how others migh ... Show More
44m 24s
Feb 2025
Science, Interrupted: Part 1
Genetic engineering breakthroughs in the late 1960s and early 1970s came with a lot of promise—and peril too. Fears about what could happen with recombinant DNA experiments put scientists in the middle of a moral dilemma. Did they have a responsibility to consider how others migh ... Show More
41m 55s
Recommended Episodes
Aug 2023
What difference could new Alzheimer’s disease drugs make?
Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ... Show More
28m 37s
Mar 2023
Julie Williams on Alzheimer’s disease
There are almost a million people in the UK living with dementia, and Alzheimer’s is the most common form. But the disease actually starts long before any noticeable symptoms appear, and over the past decade, studies have shown that it is much more complex than previously thought ... Show More
28m 21s
Feb 2022
What you can do to prevent Alzheimer's | Lisa Genova
Alzheimer's doesn't have to be your brain's destiny, says neuroscientist and author of "Still Alice," Lisa Genova. She shares the latest science investigating the disease -- and some promising research on what each of us can do to build an Alzheimer's-resistant brain. TED Talks D ... Show More
21m 41s
Sep 2021
What causes Alzheimer’s?
For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure?For more, go to http://vox.com/unexplainableIt’s a great place to sign up for our newsletter, view show t ... Show More
31m 10s
Jun 2023
TWiN 41: Alzheimer's and melanin-concentrating hormone
Vivianne explains how early in Alzheimer’s disease, the brain attempts to counteract the increased excitatory drive caused by amyloid deposition, and that melanin-concentrating hormone, produced during sleep, is involved in this protective response. Hosts: Vincent Racaniello, Jas ... Show More
1h 18m
Feb 2021
What you can do to prevent Alzheimer's | Lisa Genova
Alzheimer's doesn't have to be your brain's destiny, says neuroscientist and author of "Still Alice," Lisa Genova. She shares the latest science investigating the disease -- and some promising research on what each of us can do to build an Alzheimer's-resistant brain. Hosted on A ... Show More
14m 6s
Jul 2023
How close are we to ending Alzheimer's?
A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ... Show More
48m 39s
Mar 2023
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ... Show More
13m 46s
Mar 2022
The Science Behind Mental Afflictions
In “A Molecule Away From Madness,” the neurologist Sara Manning Peskin writes about the errant molecular activity that underlies many serious mental afflictions. Peskin’s book, reminiscent of the work of Oliver Sacks, conveys its scientific information through narrative.“I wanted ... Show More
58m 48s